# Nanology Labs

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nanology-labs

- Industry: Pharmaceuticals
- Headquarters: Toronto, Canada
- Website: www.nanologylabs.com
- Total disclosed funding: $3M
- Latest round: Seed (May 17, 2021)
- Investors on record: 7

## About

Nanology Labs Inc. develops advanced delivery technologies to enhance the effectiveness of biological therapeutics, focusing on innovative solutions for precise drug administration.Founded in 2018, Nanology Labs Inc. is headquartered in Toronto, Canada. The company specializes in advanced delivery technologies for biologics and has completed a total of 4 deals, with the most recent one on May 17, 2021. In this round, they raised USD 3.000 mn in Seed funding led by Fight Against Cancer Innovation Trust, with participation from MEDTEQ+, Ontario Brain Institute, and Ontario Centre of Innovation.Nanology Labs Inc. focuses on advanced delivery technologies designed to enhance the efficacy of biological therapeutics. Their core offerings target innovative delivery systems that enable controlled release of therapeutic agents, particularly for biologics like monoclonal antibodies and gene therapies. Their primary customers are pharmaceutical and biotechnology firms that improve the delivery of biological products, and they operate in North America, Europe, and select regions in Asia, where demand for advanced therapeutic solutions is growing.The revenue structure of Nanology Labs Inc. is centered on B2B transactions through partnerships with pharmaceutical and biotech firms, involving licensing of proprietary technologies and collaboration agreements. Pricing plans include milestone payments and royalties based on sales of therapeutics using their delivery systems, fostering long-term relationships and sustainable growth.In May 2021, Nanology Labs Inc. secured USD 3.000 mn in Seed funding to advance the development of T-MX, a smart nanomedicine aimed at treating tumor hypoxia. The company is focused on rolling out this product while targeting expansion into new markets across Europe and Asia by 2023, enhancing their international presence to meet growing demand for innovative therapeutic solutions.

## Funding rounds

- Seed, May 17, 2021, $3M — Ontario Centre of Innovation, Fight Against Cancer Innovation Trust, Ontario Brain Institute, MEDTEQ+
- Seed, Apr 8, 2019 — Fight Against Cancer Innovation Trust, Creative Destruction Lab, McNamara Family Investments, Utest

## Investors

- Fight Against Cancer Innovation Trust (https://capitalatlas.ai/funds/fight-against-cancer-innovation-trust) — Seed
- Creative Destruction Lab (https://capitalatlas.ai/funds/creative-destruction-lab) — Seed
- McNamara Family Investments (https://capitalatlas.ai/funds/mcnamara-family-investments) — Seed
- Utest — Seed
- Ontario Centre of Innovation (https://capitalatlas.ai/funds/ontario-centre-of-innovation) — Seed
- Ontario Brain Institute — Seed
- MEDTEQ+ — Seed